, Volume 106, Issue 3, pp 321–329 | Cite as

Fluoxetine decreases brain temperature and REM sleep in Syrian hamsters

  • Bo Gao
  • Wallace C. DuncanJr
  • Thomas A. Wehr
Original Investigations


The antidepressant drug, fluoxetine (FLX), a selective serotonin reuptake inhibitor, was administered to Syrian hamsters, and its acute and chronic effects on EEG sleep and hypothalamic temperature were recorded. Acute fluoxetine treatment at doses of 5, 10, 20 and 40 mg/kg decreased REM sleep and hypothalamic temperature in a dose-dependent manner. It increased NREM sleep, and, at doses of 20 and 40 mg/kg, it increased wakefulness. At 40 mg/kg, it decreased motor activity. During chronic treatment, tolerance developed to FLX's REM sleep-inhibiting effects, but tolerance did not develop to FLX's hypothalamic temperature-decreasing effects. Chronic FLX treatment produced circadian phase-dependent decreases in temperature beyond those that were observed during acute treatment. The apparent dissociation during chronic treatment between FLX's temperature-lowering effects and its REM-decreasing effects might be related to long-term changes in 5HT receptor function or FLX pharmacokinetics.

Key words

Fluoxetine REM sleep Hypothalamic temperature Syrian hamster Serotonin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bardeleben UV, Steiger A, Gerken A, Holsboer F (1988) Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls. Int Clin Psychopharmacol 4 [suppl 1]:1–5Google Scholar
  2. Bergstrom RF, Lemberger L, Farid NA, Wolen RL (1988) Clinical pharmacology and pharmacokinetics of fluoxetine: a review. Br J Psychiatry 153 [suppl 3]:47–50Google Scholar
  3. Blier P, Chaput Y, Montigny CD (1988) Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 337:236–254Google Scholar
  4. Clark WG, Lipton JM (1986) Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants: II. Neurosci Biobehav Rev 10:153–220Google Scholar
  5. Edgar DM, Seidel WF, Dement WC (1990) Effects of buspirone on sleep-wake and body temperature circadian rhythms in the rat. Sleep Res 19:59Google Scholar
  6. Farid NA, Bergstrom RF, Lemberger L, Ziege EA, Tenbarge J, Wolen RL, Dhahir P (1986) Studies on the disposition of fluoxetine and radioactive isotopes. 15th CINP Congress, Puerto Rico, Collegium Internationale NeuropsychopharmacologiumGoogle Scholar
  7. Feldberg W, Lotti VJ (1967) Temperature response to monoamines and inhibitor of MAO injected into the cerebral ventricles of rats. Br J Pharmacol Chemother 31:152–161Google Scholar
  8. Fornal C, Radulovacki M (1980) Fenfluramine, fluoxetine and quipazine suppress sleep in rats. Soc Neurosci Abstr 6:51Google Scholar
  9. Fuller RW, Perry KW, Molloy BB (1974) Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine (Lilly 110 140). Life Sci 15:1161–1171Google Scholar
  10. Fuller RW, Perry KW, Molloy BB (1975) Effect of 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. J Pharmacol Exp Ther 193:796–803Google Scholar
  11. Gao B, Duncan WC (1989) Antidepressant drug treatment with an MAOI decreased hypothalamic temperature in Syrian hamsters. 19th Annual Meeting Society for Neuroscience Abstracts 15:852Google Scholar
  12. Gao B, Duncan WC, Wehr TA (1991) Clorgyline-induced reduction in body temperature and its relationship to vigilance states in Syrian hamsters. Neuropsychopharmacology 4:187–197Google Scholar
  13. Garattini S, Mennini T, Samanin R (1989) Reduction of food intake by manipulation of central serotonin. Br J Psychiatry 155 [suppl 8]:41–51Google Scholar
  14. Guan XM, McBride WJ (1988) Fluoxetine increases the extracellular levels of serotonin in the nucleus accumbens. Brain Res Bull 21:43–46Google Scholar
  15. Gudelsky GA, Koenig JI, Meltzer HY (1986) Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Neuropharmacology 25:1307–1313Google Scholar
  16. Hilaire SK-DS, Merica H, Gaillard JM (1984) The effects of indalpine — a selective inhibitor of 5-HT uptake — on rat paradoxical sleep. Eur J Pharmacol 98:413–418Google Scholar
  17. Hwang EC, Magnussen I, Van Woert MH (1980) Effects of chronic fluoxetine administration on serotonin metabolism. Res Commun Chem Pathol Pharmacol 29:79–98Google Scholar
  18. Kleinlogel H, Burki HR (1987) Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat. Neuropsychobiology 17:206–212Google Scholar
  19. Kluger MJ, Conn CA, Franklin B, Freter R, Abrams GD (1990) Effect of gastrointestinal flora on body temperature of rats and mice. Am J Physiol 258:R552–557Google Scholar
  20. Kulakowski EC, Hurst JH, Miller T, Linnoila M, Lovenberg W (1984) The hypothermic effect of 4-(5,6-dimethyl-2-benzofuranyl) piperidine HGL (CGP 6085 A) in Wistar kyoto rats Life Sci 35:1329–1335Google Scholar
  21. Lin MT (1978) Effects of specific inhibitors of 5-hydroxytryptamine uptake on thermoregulation in rats. J Physiol 284:147–154Google Scholar
  22. Marsden CA, Conti J, Strope E, Curzon G, Adams RN (1979) Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltametry. Brain Res 171:85–99Google Scholar
  23. McCleary P, Leander JD (1982) Meperidine-induced hypothermia in the rat. Neuropharmacology 21:1337–1341Google Scholar
  24. Montgomery SA (1989) The efficacy of fluoxetine as an antidepressant in the short and long term. Int Clin Psychopharmacol 4 [suppl 1]:11–39Google Scholar
  25. Myers RM, Yaksh TL (1968) Feeding and temperature responses in the unrestrained rat after injections of cholinergic and aminergic substances into the cerebral ventricales. Physiol Behav 3:917–928Google Scholar
  26. Nicholson AN, Pascoe PA (1988) Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor. Neuropharmacology 27:597–602Google Scholar
  27. Obal Jr F, Rubicsek G, Alfoldi P, Sary G, Obal F (1985) Changes in the brain and core temperatures in relation to various arousal states in rats in the light and dark periods of the day. Pflugers Arch 404:73–79Google Scholar
  28. Parmeggiani PL (1980) Temperature regulation during sleep: a study in homeostasis. In: Orem J, Barnes CD (eds) Physiology in sleep (Research topics in physiology). Academic Press, New York, pp 97–143Google Scholar
  29. Parmeggiani PL (1987) Interaction between sleep and thermoregulation: an aspect of the control of behavioral states. Sleep 10:426–435Google Scholar
  30. Pastel RH, Fernstrom JD (1987) Short-term effects of fluoxetine and triflouromethylphenylpiperazine on electroencephalographic sleep in the rat. Brain Res 436:92–102Google Scholar
  31. Pawlowski L (1984) Amitriptyline and femoxetine, but not clomipramine or citalopram, antagonize hyperthermia induced by directly acting 5-hydroxytryptamine-like drugs in heat adapted rats. J Pharm Pharmacol 36:197–199Google Scholar
  32. Reigle TG, Wolf HH (1974) Potential neurotransmitters and receptor mechanisms involved in the central control of body temperature in golden hamsters. J Pharmacol Exp Ther 189:97–109Google Scholar
  33. Reyes RB, Hill SY, Kupfer DJ (1983) Effects of acute doses of zimelidine on REM sleep in rats. Psychopharmacology 80:214–216Google Scholar
  34. Reyes RB, Hill SY, Kupfer DJ (1986) Effects of repeated zimelidine administration on sleep parameters in the rat. Psychopharmacology 88:54–57Google Scholar
  35. Ross RJ, Ball WA, Gresch PJ, Morrison AR (1990) REM sleep suppression by monoamine reuptake blockade: development of tolerance with repeated drug administration. Biol Psychiatry 28:231–239Google Scholar
  36. Sakaguchi S, Glotzbach SG, Heller HC (1979) Influence of hypothalamic and ambient temperatures on sleep in kangaroo rats. Am J Physiol 237:R80-R88Google Scholar
  37. Schmidt MJ, Fuller RW, Wong DT (1988) Fluoxetine, a highly selective serotonin reptake inhibitor: a review of preclinical studies. Br J Psychiatry 153 [suppl 3]:40–46Google Scholar
  38. Shipley JE, Kupfer DK, Dealy RS, Griffin SJ, Coble PA, McEachran AB, Grochocinski VJ (1984) Differential effects of amitriptyline and of zimelidine on the sleep electroencephalogram of depressed patients. Clin Pharmacol Ther 36:251–259Google Scholar
  39. Slater IH, Jones GT, Moore RA (1978) Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake. Neuropharmacology 17:383–389Google Scholar
  40. Sommerfelt L, Hauge ER, Ursin R (1987) Similar effect on REM sleep but differential effect on slow wave sleep of the two 5-HT uptake inhibitors zimeldine and alaproclate in cats and rats. J Neural Transm 68:127–144Google Scholar
  41. Vogel GW (1975) A review of REM sleep deprivation. Arch Gen Psychiatry 32:749–761Google Scholar
  42. Vogel GW (1983) Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs. Prog Neuro Psychopharmacol Biol Psychiatry 7:343–349Google Scholar
  43. Wehr TA (1990) Sleep loss: a preventable cause of mania and other excited states. J Clin Psychiatry 50 [12, suppl]:8–16Google Scholar
  44. Wong DT, Bymaster FP (1981) Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine. Res Comm Chem Path Pharmacol 32:41–51Google Scholar
  45. Wong DT, Horng JS, Bymaster FP, Hauser KL, Molloy BB (1974) A selective inhibitor of serotonin uptake: Lilly 110 140, 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine. Life Sci 15:471–479Google Scholar
  46. Wong DT, Bymaster FP, Horng JS, Molloy BB (1975) A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine. J Pharmacol Exp Ther 193:804–811Google Scholar
  47. Wong DT, Reid LR, Bymaster FP, Threlkeld PG (1985) Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors. J Neural Transm 64:251–269Google Scholar
  48. Wozniak KM, Aulakh CS, Hill JL, Murphy DL (1988) The effect of 8-OH-DPAT on temperature in the rat and its modification by chronic antidepressant treatments. Pharmacol Biochem Behav 30:451–456Google Scholar
  49. Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL (1988) Serotonergic responsivity in obsessive-compulsive disorder. Arch Gen Psyhiatry 45:167–172Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Bo Gao
    • 1
  • Wallace C. DuncanJr
    • 1
  • Thomas A. Wehr
    • 1
  1. 1.Clinical Psychobiology BranchNational Institute of Mental HealthBethesdaUSA

Personalised recommendations